Aurobindo Pharma Ltd.    
13 Aug 2020, 08:23PM
881.30
-5.66%
Business Standard
Margins expected to improve on product mix and volume growth
Aurobindo Pharma Ltd.    
13 Aug 2020, 12:33PM
881.30
-5.66%
Earnings Call Transcript - Q1FY21 for Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript

Aurobindo Pharma Ltd.    
13 Aug 2020, 12:00AM
881.30
-5.66%
ICICI Securities Limited
US key growth driver despite recent compliance upheavals After filing its first ANDA in the US in 2003, the company has come a long way as current ANDA filings are at 604. US revenues have grown from ~US$100 million in 2009 crossing $1.6 billion sales as on 2020. In rupee terms, US sales have grown at 17% CAGR to | 11484 crore in FY16-20. US formulations now constitute 50% of total turnover, up from 30% in FY13. Despite calling off the acquisition of Sandoz' US dermatology and oral solid portfolio, we expect US revenue size to reach | 14925 crore in FY22E at a...
Aurobindo Pharma Ltd. has an average target of 808.80 from 11 brokers.
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:56PM
881.30
-5.66%
AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation
BSE India
Please refer to our letter dated August 10, 2020 wherein we have intimated the schedule of Investors/ Analysts call on August 13, 2020. In this connection, we enclose herewith the presentation that would be used in the Investors / Analysts call on the Un-audited Financial Results of the Company for the first Quarter ended June 30, 2020. The presentation is also being uploaded in the following weblink of the Company. https://www.aurobindo.com/investors/results-reports-presentations/investor-presentations/
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:51PM
881.30
-5.66%
AUROBINDO PHARMA LTD. - 524804 - Book Closure For Payment Of Interim Dividend
BSE India
Please refer to our letter dated August 3, 2020 wherein we have informed that the Register of Members and Share Transfer Books of the Company are being closed from August 25, 2020 to August 27, 2020 (both days inclusive) for the purpose of 33rd Annual General Meeting of the Company. We hereby further inform that the aforesaid book closure dates will also be considered to determine the entitlement of the shareholders to the aforesaid interim dividend of 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the year 2020-21 as approved by the Board on August 12, 2020 and the same will be paid on or before September 4, 2020.
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:44PM
881.30
-5.66%
AUROBINDO PHARMA LTD. - 524804 - Board declares Interim Dividend
BSE India
Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2020, inter alia, has approved an Interim Dividend @ 125% i.e. Rs. 1.25 (Rupee one and paise twenty five) per equity share of Re. 1/- each on the equity share capital of the Company for the Financial Year 2020-21.
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:43PM
881.30
-5.66%
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:39PM
881.30
-5.66%
AUROBINDO PHARMA LTD. - 524804 - Outcome Of Board Meeting Held On August 12, 2020.
BSE India
The Board of Directors of the Company at its meeting held today, August 12, 2020, has, inter alia, transacted the following businesses: 1. Approved the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Un-audited Financial Results along with the Limited Review Reports of the Statutory Auditors of the Company. 2. Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. We also enclose a copy of the Press Release on Un-audited Financial Results of the Company for the First Quarter ended June 30, 2020.
Aurobindo Pharma Ltd.    
12 Aug 2020, 07:30PM
881.30
-5.66%
AUROBINDO PHARMA LTD. - 524804 - Outcome Of Board Meeting Held On August 12, 2020.
BSE India
The Board of Directors of the Company at its meeting held today, August 12, 2020, has, inter alia, transacted the following businesses: 1. Approved the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We enclose herewith the said Un-audited Financial Results along with the Limited Review Reports of the Statutory Auditors of the Company. 2. Approved an Interim Dividend @ 125% i.e Rs.1.25 (Rupee one and paise twenty five) per equity share of Re.1/- each on the equity share capital of the Company for the Financial Year 2020-21. The Board meeting commenced at 4.00 p.m. and concluded at 7.00 p.m.
default
Aurobindo Pharma Ltd.    
11 Aug 2020
881.30
-5.66%
Business Today
The 70-year-old was admitted to the Aurobindo Hospital in Indore, Madhya Pradesh
Aurobindo Pharma Ltd. has an average target of 808.80 from 11 brokers.
  • ICICI Securities Limited increased Buy price target of Aurobindo Pharma Ltd. to 1100.0 on 13 Aug, 2020.
  • Stock Price (811.95) crossed above 30 Day SMA (799.75) on 29 July, 2020
  • Month Change by 22.11% (Crossed threshold 20%) on 10 June, 2020
  • Week Change by 25.2% (Crossed threshold 20%) on 21 April, 2020
  • Day Change by 19.12% (Crossed threshold 15%) on 21 April, 2020
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Aug. 21, 20201.25INTERIM-
Feb. 17, 20201.75INTERIMFeb. 18, 2020
Nov. 21, 20191.25INTERIMNov. 23, 2019
Feb. 15, 20191.25INTERIMFeb. 19, 2019
Nov. 20, 20181.25INTERIMNov. 22, 2018
All dividends by AUROPHARMA
Ex-Date Dividend Bonus Ratio Record Date
July 20, 20151:1July 21, 2015
March 7, 20001:1April 1, 2000
All bonuses by AUROPHARMA
Ex-Date Dividend Old FVNew FV Record Date
Feb. 10, 201151Feb. 11, 2011
Oct. 23, 2003105Oct. 31, 2003
All splits by AUROPHARMA